Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Clinical trial NCT02339558 · COMPLETED

Trial details

NCT number: NCT02339558
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Nonkeratinizing Carcinoma Recurrent Nasopharynx Carcinoma Stage III Nasopharyngeal Carcinoma AJCC v7 Stage IV Nasopharyngeal Carcinoma AJCC v7 Stage IVA Nasopharyngeal Carcinoma AJCC v7 Stage IVB Nasopharyngeal Carcinoma AJCC v7 Stage IVC Nasopharyngeal Carcinoma AJCC v7

Start date: 2015-07-21
Primary completion: 2018-06-16
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.